6-Chloro-7-((2-morpholinoethyl)amino)quinoline-5,8-dione
| Title | Journal |
|---|---|
| Identification of potent Yes1 kinase inhibitors using a library screening approach. | Bioorganic & medicinal chemistry letters 20130801 |
| Using small molecules to target protein phosphatases. | Bioorganic & medicinal chemistry 20110401 |
| Pharmacology and antitumor activity of a quinolinedione Cdc25 phosphatase inhibitor DA3003-1 (NSC 663284). | Anticancer research 20070101 |
| The when and wheres of CDC25 phosphatases. | Current opinion in cell biology 20060401 |
| Synthesis and biological evaluation of novel heterocyclic quinones as inhibitors of the dual specificity protein phosphatase CDC25C. | Bioorganic & medicinal chemistry letters 20060101 |
| Down-regulation of survivin in nitric oxide-induced cell growth inhibition and apoptosis of the human lung carcinoma cells. | The Journal of biological chemistry 20040507 |
| NAD(P)H:quinone oxidoreductase-1-dependent and -independent cytotoxicity of potent quinone Cdc25 phosphatase inhibitors. | The Journal of pharmacology and experimental therapeutics 20040401 |
| Dual G1 and G2 phase inhibition by a novel, selective Cdc25 inhibitor 6-chloro-7-[corrected](2-morpholin-4-ylethylamino)-quinoline-5,8-dione. | The Journal of biological chemistry 20021206 |
| Discovery and biological evaluation of a new family of potent inhibitors of the dual specificity protein phosphatase Cdc25. | Journal of medicinal chemistry 20011122 |